Skip to main content
. 2022 Sep 14;13:945592. doi: 10.3389/fphar.2022.945592

FIGURE 1.

FIGURE 1

Alpha-1 blockers and susceptibility to COVID-19 study design schematic. We highlight eligibility criteria, exposure definitions, adjustment strategies, index date specification (horizontal black arrow) and outcome definitions and time-at-risk. Exposure involves prescriptions to drugs with RxNorm ingredients that map to medications indicated for treatment of BPH.